Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)

The National Heart, Lung and Blood Institute (NHLBI) seeks to advance its mission by supporting a consortium to phenotype 0-2 year old children with severe viral lower respiratory tract infections (LRTI) with follow up until pre-school age for pulmonary sequelae. NHLBI intends to utilize the paired activity codes U24 to fund the Data and Analytics Co-ordinating Center (DACC, FOR-25-033) and the linked UG3/UH3 (Phased award with built-in milestones for transition, FOR-HL-25-032) to fund one Clinical Coordinating Center (CCC) and Biorepository along with four Clinical Centers (CCs).

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UG3/UH3 activity code. Investigators with expertise and insights into this area are encouraged to begin to consider applying for this NOFO. Grant authorities that allow NHLBI to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.